Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
5,061,592
-
Total 13F shares
-
226,399
-
Share change
-
+96,413
-
Total reported value
-
$337,332
-
Price per share
-
$1.49
-
Number of holders
-
14
-
Value change
-
+$143,732
-
Number of buys
-
5
-
Number of sells
-
2
Institutional Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q3 2025
As of 30 Sep 2025,
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
226,399 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, DRW Securities, LLC, TWO SIGMA INVESTMENTS, LP, TWO SIGMA SECURITIES, LLC, SBI Securities Co., Ltd., MORGAN STANLEY, UBS Group AG, OSAIC HOLDINGS, INC., and NATIONAL BANK OF CANADA /FI/.
This page lists
14
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.